GALNT6 and breast carcinoma: In this regard, while searching for disseminated tumor cell biomarkers in breast cancer, we previously found that GALNT6 expression assessment in bone marrow aspirates was helpful to identify a subset of patients with worse survival rates among the negative lymph node group, suggesting its role as prognostic marker [19].